Sinusitis affects about 14% of the population. Its direct medical costs amount to billions of dollars annually. Indirectly, its cost is greatly magnified by the staggering amount of lost hours of work or school. Current methods of cost analysis indicate that sinusitis usurps nearly 1% or the entire Gross National Product.
The conventional medical treatment involves the use of broad spectrum anitbiotics, antihistamines with or without decongestants, and mucolytic agents in patients with uncomplicated sinusitis. The choice of medications is based on the patient's medical condition and there are times when the choice may be severely restricted, due to another medical condition that patient may be experiencing.
The surgical treatment of sinusitis has seen a radical change in the recent past, and this is due to a better understanding of the physiology of sinuses and their functions. Image-Guided sinus surgery, as introduced in the USA in 1984, is based on the extensive clinical work performed by Professor Messerklinger and his associates from Graz, Austria.
There have been various advances in technology, instrumentation and adjunctive aids in image-guided sinus surgery. In this presentation, the most pertinent advances, which have patient applications, will be discussed in detail.